India's own first drug - from Biocon.
...a's largest publicly-held biotechnology firm, launched its second novel 'lab-to-market' molecule, Alzumab,...around ₹ 7,500 a vial, will cost half as much as the currently available drugs - from Pfizer and J&a...3902 days ago
2780 days ago